CIDRAP newsletters options
All 23 cases involve hospitalization.
Vaccine uptake at 30 days was not significantly higher in either intervention group.
Histoplasmosis, blastomycosis, and coccidioidomycosis, which are often linked to contaminated soil, occur in different parts of the US.
This is the 18th case of human H5N1 avian flu in Cambodia this year.
The loss may threaten the population's future by reducing the number of surviving pups and highlights the need for continued, intensive monitoring.
If confirmed, it will be the first human bird flu case in the US since February.
At day 28, 93% of people who received the single-dose therapy were free of parasites in their blood, compared with 90% of multiple-dose recipients.
The rate was quadruple in those 75 and older, but those findings demonstrate less statistical power.
In late summer, private landowners reported seeing the emaciated deer, which was euthanized and tested in September.
A wild poliovirus type 1-positive sample was isolated from wastewater in Hamburg, Germany, this week.
Though deadly anaphylaxis had been considered a theoretical outcome of the allergy, it had not yet been seen until this case.
The vaccine elicited both antibody and cellular immune responses.
Last year the US had 285 measles cases.
Among more than 140,000 visits for ear infection, only 15% used watchful waiting, but treatment failure rates were low and similar to those for children who received antibiotics immediately.
Half of the Staphylococcus epidermidis isolates found in raw milk from dairy cattle and sheep were multidrug resistant.
Ethiopian health authorities are ramping up their response and conducting lab tests to identify the cause of the infection and stop further transmission.
Nineteen-month antibody geometric mean titers were higher among children than in adults, similar to after the primary series.
Early data from the UK and Japan show that the H3N2 subclade K was represented in 90% of flu samples.
The global TB incidence rate fell by 2% in 2024, and TB deaths fell by 3%, but WHO officials say the progress could be wiped out by funding cuts.
Vaccination was 82% effective against hospital admission for any RSV-related respiratory illness and 87% effective against admission for severe RSV.
